Plerixafor
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06809 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | indolent plasma cell myeloma | KG + DL |
| 2 | CMM7 | KG + DL |
| 3 | pediatric leptomeningeal melanoma | KG + DL |
| 4 | epithelioid cell uveal melanoma | KG + DL |
| 5 | bronchitis | KG + DL |
| 6 | vulvar melanoma (disease) | KG + DL |
| 7 | myeloid leukemia | KG + DL |
| 8 | melanoma | KG + DL |
| 9 | cecum villous adenoma | KG + DL |
| 10 | cecum neuroendocrine tumor G1 | KG + DL |
| 11 | rectosigmoid junction neoplasm | KG + DL |
| 12 | colonic neoplasm | KG + DL |
| 13 | lipoma of colon | KG + DL |
| 14 | cecal disease | KG + DL |
| 15 | colon leiomyoma | KG + DL |
| 16 | benign neoplasm of cecum | KG + DL |
| 17 | colonic lymphangioma | KG + DL |
| 18 | cavernous hemangioma of colon | KG + DL |
| 19 | intellectual disability, autosomal dominant 55, with seizures | KG + DL |
| 20 | medullary cystic kidney disease | KG + DL |
| 21 | rheumatoid arthritis | KG + DL |
| 22 | colorectal gastrointestinal stromal tumor | KG + DL |
| 23 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 24 | colorectal hamartoma | KG + DL |
| 25 | colorectal leiomyoma | KG + DL |
| 26 | bronchial neoplasm (disease) | KG + DL |
| 27 | brachydactyly-syndactyly syndrome | KG + DL |
| 28 | neutrophil immunodeficiency syndrome | KG + DL |
| 29 | tooth agenesis, selective, X-linked, 1 | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.